DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Home > Aktien > BioMimetic Therapeutics Aktie > Nachrichten zu BioMimetic Therapeutics

BioMimetic Therapeutics Aktie [WKN: A0JMAF / ISIN: US09064X1019]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur BioMimetic Therapeutics Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur BioMimetic Therapeutics Inc.

12.03.10BioMimetic Therapeutics Reports 2009 Fourth Quarter and Year End Earnings Results
09.03.10BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting
08.03.10BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11
04.03.10BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings
17.02.10BioMimetic Therapeutics Completes Submission of PMA Application for FDA Approval of Augment™ Bone Graft
01.02.10BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened
11.12.09BioMimetic Therapeutics Ships Augment™ Bone Graft to Canadian Distributor
08.12.09Novo A/S Implements 10b5-1 Trading Plan for Purchase of Additional BioMimetic Therapeutics Shares
30.11.09BioMimetic Therapeutics, Inc. to Present at the Piper Jaffray 21st Annual Healthcare Conference
05.11.09BioMimetic Therapeutics Reports 2009 Third Quarter Earnings Results
03.11.09BioMimetic Therapeutics Receives First Orthopedic Marketing Approval for Augment™ Bone Graft
03.11.09BioMimetic Therapeutics to Report 2009 Third Quarter Financial Results on November 5
13.10.09BioMimetic Therapeutics Announces Positive Top-Line Data from its Augment™ Bone Graft North American Pivotal Trial
10.08.09BioMimetic Therapeutics Reports 2009 Second Quarter Earnings Results
07.08.09BioMimetic Therapeutics, Inc. to Present at the Canaccord Adams Global Growth Conference
06.08.09BioMimetic Therapeutics to Report 2009 Second Quarter Financial Results on August 10
25.06.09BioMimetic Therapeutics, Inc. Announces Completion of Rights Offering and Sale of Shares in Standby Purchase
23.06.09BioMimetic Therapeutics, Inc. Announces Preliminary Results of Rights Offering
18.06.09BioMimetic Therapeutics Announces Highlights from Annual Meeting of Stockholders
17.06.09BioMimetic Therapeutics Submits First Two PMA Modules to FDA
11.06.09BioMimetic Therapeutics, Inc. Announces Extension of Rights Offering
05.06.09BioMimetic Therapeutics, Inc. to Present at the Noble Financial Fifth Annual Equity Conference
04.06.09BioMimetic Therapeutics, Inc. Announces Launch of Rights Offering
14.05.09BioMimetic Therapeutics, Inc. to Present at the Deutsche Bank 34th Annual Healthcare Conference
07.05.09BioMimetic Therapeutics Reports 2009 First Quarter Earnings Results
05.05.09BioMimetic Therapeutics to Report 2009 First Quarter Financial Results on May 7
16.04.09BioMimetic Therapeutics, Inc. Announces Record Date for Rights Offering
06.04.09BioMimetic Therapeutics, Inc. Announces an $8 Million Private Placement
20.03.09BioMimetic Therapeutics President and CEO Adopts 10b5-1 Trading Plan
12.03.09BioMimetic Therapeutics Reports 2008 Fourth Quarter and Year End Results
11.03.09BioMimetic Therapeutics to Report 2008 Fourth Quarter and Year End Financial Results on March 12
10.03.09SAS Provides BioMimetic With Serious Analytics for Clinical Trials
19.02.09BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings
05.02.09BioMimetic Therapeutics, Inc. to Present at BIO CEO and Investor Conference
07.01.09BioMimetic Therapeutics, Inc. Closes Enrollment with 436 Patients in North American Pivotal Study for Augment™ Bone Graft
11.12.08BioMimetic Therapeutics, Inc. Achieves Patient Enrollment Target (396) in North American Pivotal Study for Augment™ Bone Graft
21.11.08BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent
21.11.08BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent
13.11.08BioMimetic Therapeutics Ranked 181st Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
10.11.08BioMimetic Therapeutics Reports 2008 Third Quarter Results

Anzeige

ANZEIGE

Seite: 12
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon